Skip to main content
Mauna Kea Technologies logo

Mauna Kea Technologies — Investor Relations & Filings

Ticker · MKEA ISIN · FR0010609263 LEI · 5493007KMDG4MFIGJJ63 PA Manufacturing
Filings indexed 780 across all filing types
Latest filing 2014-09-23 Regulatory Filings
Country FR France
Listing PA MKEA

About Mauna Kea Technologies

https://www.maunakeatech.com/en/

Mauna Kea Technologies is a medical device company that develops and markets the Cellvizio® platform, a real-time in vivo cellular imaging system. The platform utilizes Confocal Laser Endomicroscopy (CLE) technology, enabling physicians to visualize tissue at the cellular level during medical procedures. This "optical biopsy" is performed using flexible, miniature fiber-optic probes (Confocal Miniprobes™) that are compatible with standard endoscopes. The core function of Cellvizio® is to provide immediate microscopic visualization, which aids in accelerating diagnosis, informing treatment strategies, and improving the precision of therapeutic interventions. Key applications include gastroenterology (for conditions such as Barrett's esophagus and pancreatic cysts), interventional pulmonology (lung cancer diagnostics), urologic oncology, and neurosurgery. The technology supports enhanced surgical procedures, including real-time margin assessment, and is being integrated with robotic surgery and AI-assisted imaging systems.

Recent filings

Filing Released Lang Actions
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 95% confidence The document is a press release dated September 23rd, 2014, announcing the success and presentation of the company's product (Cellvizio) at the EUS 2014 conference. It details clinical value dissemination, expert presentations, and live demonstrations. This type of announcement, focusing on company achievements, product updates, or participation in industry events, does not fit the specific financial reporting categories (10-K, IR, ER, etc.). It is a general corporate announcement. Since it is not a formal regulatory filing like a Director's Dealing (DIRS) or a Major Shareholding Notification (MRQ), and it is not a transcript (CT) or a presentation (IP), the most appropriate general category for corporate news that doesn't fit elsewhere is 'Regulatory Filings' (RNS), which serves as a broad category for miscellaneous corporate announcements not covered by the other specific codes.
2014-09-23 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 85% confidence The document is a press release from Mauna Kea Technologies dated September 23, 2014, announcing positive results and clinical value demonstrations of their Cellvizio product at the EUS 2014 conference. This type of announcement, detailing company achievements, product updates, or participation in industry events, does not fit the specific financial reporting categories (10-K, IR, ER, MRQ) or corporate governance filings (DEF 14A, DIRS). It is a general business update. Since it is not a transcript (CT), a formal presentation (IP), or a notice of a specific financial event (DIV, CAP), the most appropriate general category for a non-standard regulatory or business announcement is 'Regulatory Filings' (RNS), which serves as a fallback for miscellaneous corporate communications that are not explicitly defined elsewhere.
2014-09-23 French
Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 95% confidence The document is titled "Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social" (Monthly information relating to the total number of voting rights and shares comprising the share capital). It explicitly references the French Commercial Code (Article L233-8-II) and the General Regulation of the AMF (Autorité des Marchés Financiers). It provides a table detailing the number of shares and total gross/net voting rights as of August 29, 2014. This content directly relates to mandatory disclosures concerning the total number of shares and voting rights, which is a specific regulatory filing requirement in France, often related to capital structure changes or mandatory periodic updates. While it is a periodic report, it is not a comprehensive financial report (10-K or IR). It is a specific disclosure about the capital structure and voting rights. Among the provided codes, 'SHA' (Share Issue/Capital Change) or 'RNS' (Regulatory Filings) are the closest fits. Given the specific nature of reporting total voting rights and shares, which is a key component of capital structure disclosure, 'SHA' is a strong candidate, although 'RNS' is a safe fallback. However, since the core content is about the composition of the capital and voting rights, which directly impacts share structure, SHA is more precise than the general RNS category, although it is not strictly a 'Share Issue' announcement, but rather a periodic update on the capital base. Since there is no specific code for 'Total Voting Rights Disclosure', and it is a mandatory regulatory disclosure, RNS (Regulatory Filings) is the most appropriate general category for this type of periodic, non-financial, capital-related regulatory update that doesn't fit 'SHA' (which usually implies an issuance/buyback event) or 'DIV'. Given the context of mandatory regulatory reporting on capital structure components, RNS is the best fit as a specific regulatory disclosure.
2014-09-02 French
Communicated under the obligation to provide permanent information / Communication relating to accounts, results, and turnover
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the first half of 2014 (H1 2014), containing detailed financial statements (income statement data), analysis of business trends, geographic performance, and operational updates. It is not merely an announcement of a report, as it provides the actual financial data and analysis within the text. Therefore, it fits the definition of an Interim/Quarterly Report (IR). H2 2014
2014-08-28 English
Communiqués au titre de l'obligation d'information permanente / Communiqué sur comptes, résultats, chiffres d’affaires
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the first half (S1) of 2014, containing detailed financial statements (balance sheet/income statement data), analysis of business trends, regional performance, and management commentary. It is not a mere announcement of a report, as it provides the actual financial data and analysis. Therefore, it is classified as an Interim/Quarterly Report. H1 2014
2014-08-28 French
Communiqués de mise à disposition de documents / Modalités de mise à disposition document de référence ou de ses actualisations
Report Publication Announcement Classification · 98% confidence The document is a short announcement dated August 7, 2014, stating that Mauna Kea Technologies has registered its 'Document de Référence 2013' (2013 Reference Document) with the French financial market authority (AMF) on August 6, 2014. The text explicitly mentions the document's availability for consultation on the company's website and the AMF's website, but it does not contain the content of the reference document itself. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating that a report has been published or is available elsewhere classifies as a Report Publication Announcement (RPA). The 'Document de Référence' is a comprehensive annual filing in France, similar in scope to a 10-K, but since this text is only the announcement of its availability, RPA is the correct classification.
2014-08-07 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.